References
1. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. Int J Immunopathol Pharmacol 2006 Jan-Mar;19(1):67-79. 2. Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells. Kidney Int 2006 Apr;69(8):1393-402. 3. TNP-470 blockage of VEGF synthesis is dependent on MAPK/COX-2 signaling pathway in PDGF-BB-activated hepatic stellate cells.Biochem Biophys Res Commun 2006 Mar 3;341(1):239-44. 4. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 2006 Jan;116(1):237-48. 5. Heterodimerization of FGF-receptor 1 and PDGF-receptor-alpha: a novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Blood 2006 Mar 1;107(5):1896-902. 6. Disruption of intermolecular disulfide bonds in PDGF-BB dimers by N-acetyl-L-cysteine does not prevent PDGF signaling in cultured hepatic stellate cells. Biochem Biophys Res Commun 2005 Dec 30;338(4):1711-8.USBio References
No references available